Tag: Competition

WHAT: The Federal Trade Commission will host a workshop, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics”. Acting FTC Chairman Maureen K. Ohlhausen and U.S...

The staff of the Federal Trade Commission has issued an opinion advising Crouse Health Hospital that an exemption under the Non-Profit Institutions Act, or NPIA, applied to its proposal to sell...

The Federal Trade Commission has filed an amicus brief jointly with the Department of Justice in the case of Chamber of Commerce v. City of Seattle, which is pending before the U.S. Court of Appeals...

WHAT: The Federal Trade Commission will host a Roundtable, “ The Effects of Occupational Licensure on Competition, Consumers, and the Workforce: Empirical Research and Results”. Acting Chairman...

Red Ventures and Bankrate have agreed to a divestiture of Bankrate’s Caring.com business unit to settle Federal Trade Commission charges that their $1.4 billion merger would likely harm competition in...

The Federal Trade Commission has released its draft Strategic Plan for Fiscal Years 2018 to 2022 for public review and comment, as required under the GPRA Modernization Act of 2010, using guidance...

Federal Trade Commission staff has issued a public notice encouraging academic and industry research on the impact of certificates of public advantage (COPA) on prices, quality, access, and innovation...

The number of reverse-payment patent settlements entered into by pharmaceutical companies in fiscal year 2015 declined from fiscal year 2014, marking a second annual decrease in such settlements...

In an Initial Decision announced today, Chief Administrative Law Judge D. Michael Chappell upheld a Federal Trade Commission complaint against 1-800 Contacts, ruling that the agency has proved that...

Federal Trade Commission staff has submitted comments to Frank W. Berry, Commissioner of the Georgia Department of Community Health, supporting a Certificate of Need (CON) application filed by Lee...

The Federal Trade Commission’s Economic Liberty Task Force has announced the agenda for its second roundtable in Washington, DC on November 7, 2017, to examine empirical evidence on the effects of...

The Federal Trade Commission has announced an agenda for its upcoming workshop on competition issues related to prescription drug markets. The workshop, titled “Understanding Competition in...